Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults
Go back to Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 10.38 +0.27 (2.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.11 | 52 Week High | $9.23 | |||
| Open | $10.38 | 52 Week Low | $1.16 | |||
| Day High | $10.55 | P/E | N/A | |||
| Day Low | $10.21 | EPS | $-0.30 | |||
| Volume | 1,800,302 | |||||
